Thailand’s HIV crisis is back after health chiefs revealed more than half a million people in the kingdom are living with the ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Winning Founding Managing Editor and Executive Director of Cns (Citizen News Service) and Is a Feminist, Health and Development Justice Advocate.Scientific research has gifted us with a range of ...

Results from studies have shown the overwhelming efficacy of twice-yearly injections of Lenacapavir (LEN) in the prevention of HIV infections compared to standard oral preventive HIV medicines ...

A new way to prevent HIV infection is generating great buzz -- and more than a bit of controversy -- at this week’s AIDS 2024 Conference in Munich. The treatment consists of a twice-yearly ...

Two shots a year of a drug currently used to treat HIV infections were dramatically effective at preventing infections in a study among young women and adolescent girls in Africa.

As U.S. HIV/AIDS aid wanes, Thailand thrives with local leadership and community care — offering a model for others amid a global funding crisis.

Another gamechanger which helped Thailand progress towards ending AIDS is generic manufacturing of lifesaving antiretroviral ...

Although world is not on track to end AIDS by 2030 but it is no less than a miracle when we take into account the scientific ...

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections. FDA approves new twice-yearly HIV shot. What to know ...